Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogeneic hematopoietic stem cells-Central Hospital, Nancy, France
- Development stage
- Unknown
- Lead developer
- CHRU Nancy
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Allogeneic hematopoietic stem cells used in the context of the REAL-GREFFE observational study (NCT03357172) conducted at Central Hospital (Hôpital Brabois), Nancy, France. These cells are obtained from matched related or unrelated donors and are used as a cellular therapy for patients with hematologic malignancies or other disorders requiring stem cell transplantation. The study specifically investigates the immune cell composition of the graft—including effector T cells, regulatory T cells (Tregs), invariant natural killer T (iNKT) cells, and myeloid-derived suppressor cells (MDSC)—and correlates these subsets with post-transplant outcomes such as graft-versus-host disease (GVHD), disease relapse, and infections. The therapy is often administered following conditioning regimens that may include anti-lymphocyte globulin (ATLG or ATG) for GVHD prophylaxis.
- Other names
- allogeneic hematopoietic stem cellsallogeneic HSCsREAL-GREFFE graft
Beyond the preview
Go deeper on allogeneic hematopoietic stem cells-Central Hospital, Nancy, France.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogeneic hematopoietic stem cells-Central Hospital, Nancy, France.